BRCA2 and breast carcinoma: Mutations in BRCA1 and BRCA2, which cause Hereditary Breast and Ovarian Cancer Syndrome (HBOC), account for around 80% of the 5%–10% of breast cancer cases related to rare mutations.1, 2